Early research (Phase 1)Study completedNCT00709800What this trial is testingPandemic Influenza Plasmid DNA Vaccines (Needle)Who this might be right forInfluenza Vical 56
Early research (Phase 1)Study completedNCT00694213What this trial is testingPandemic Influenza Plasmid DNA Vaccines (Needle-Free)Who this might be right forInfluenza Vical 47
Early research (Phase 1)Study completedNCT03345043What this trial is testingSafety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult SubjectsWho this might be right forInfluenza ModernaTX, Inc. 156
Testing effectiveness (Phase 2)Study completedNCT02153671What this trial is testingImmunogenicity of H5N1 Vaccine Following H5N2Who this might be right forInfluenza Vaccine PATH 43
Early research (Phase 1)Study completedNCT02335164What this trial is testingEvaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in AdultsWho this might be right forInfluenza Vaxine Pty Ltd 270
Testing effectiveness (Phase 2)WithdrawnNCT01037634What this trial is testingSafety and Efficacy of Oseltamivir in Children Younger Than One Year of AgeWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00517517What this trial is testingSafety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)Who this might be right forInfluenza Alachua Government Services, Inc. 110
Early research (Phase 1)Study completedNCT00347672What this trial is testingSafety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT01416571What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in AdultsWho this might be right forInfluenza GlaxoSmithKline 78
Testing effectiveness (Phase 2)Study completedNCT00620815What this trial is testingSafety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and AboveWho this might be right forInfluenza Novartis Vaccines 601
Early research (Phase 1)Study completedNCT01184976What this trial is testingStudy Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult MalesWho this might be right forHealthy GeneOne Life Science, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02229357What this trial is testingEvaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 VaccineWho this might be right forAvian Influenza Mahidol University 60
Early research (Phase 1)Study completedNCT01657929What this trial is testingH5-VLP + GLA-AF Vaccine Trial in Healthy Adult VolunteersWho this might be right forInfluenza A Subtype H5N1 Infection Access to Advanced Health Institute (AAHI) 105
Early research (Phase 1)Study completedNCT02274545What this trial is testingEvaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years OldWho this might be right forInfluenza A Virus, H7N9 Subtype National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT01443936What this trial is testingExperimental AD4-H5-VTN Vaccine in Healthy VolunteersWho this might be right forH5N1 Influenza National Institute of Allergy and Infectious Diseases (NIAID) 96
Testing effectiveness (Phase 2)Study completedNCT00133536What this trial is testingA/H5N1 Vaccine in Healthy Children Aged 2-9 YearsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 157
Early research (Phase 1)Study completedNCT01443663What this trial is testingEvaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza VaccineWho this might be right forH5N1 Influenza National Institute of Allergy and Infectious Diseases (NIAID) 69
Early research (Phase 1)Study completedNCT01086657What this trial is testingAn Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...Who this might be right forInfluenza A Virus, H5N1 Subtype National Institute of Allergy and Infectious Diseases (NIAID) 64
Testing effectiveness (Phase 2)Study completedNCT02213354What this trial is testingH7N9 Mix and Match With MF59 in Healthy Elderly PersonsWho this might be right forAvian Influenza National Institute of Allergy and Infectious Diseases (NIAID) 479
Early research (Phase 1)Study completedNCT03014310What this trial is testingH5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: ImmunologyWho this might be right forAvian Influenza National Institute of Allergy and Infectious Diseases (NIAID) 388